Ana Teijo-Quintans (Ana Teijo)

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Venues

Nature communications

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Carmen Riesco-Martinez, Jaume Capdevila Castillón, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo-Quintans, Yolanda Rodriguez-Gil, Beatriz Soldevilla, Rocio Garcia-Carbonero
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature communications 15 (1) (2024)
Maria Carmen Riesco-Martinez, Jaume Capdevila Castillón, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo-Quintans, Yolanda Rodriguez-Gil, Beatriz Soldevilla, Rocio Garcia-Carbonero
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature communications 15 (1) (2024)
Maria Carmen Riesco-Martinez, Jaume Capdevila Castillón, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo-Quintans, Yolanda Rodriguez-Gil, Beatriz Soldevilla, Rocio Garcia-Carbonero
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature communications 15 (1) (2024)
Beatriz Soldevilla, Alberto Lens-Pardo, Paula Espinosa-Olarte, Carlos Carretero-Puche, Sonia Molina-Pinelo, Carlos Robles, Marta Benavent, Lourdes Gomez-Izquierdo, Marta Fierro-Fernández, Patricia Morales-Burgo, Paula Jimenez-Fonseca, Beatriz Anton-Pascual, Yolanda Rodriguez-Gil, Ana Teijo-Quintans, Anna La Salvia, Beatriz Rubio-Cuesta, Maria C Riesco-Martínez, Rocio Garcia-Carbonero
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms. Molecular oncology (2023)
Beatriz Soldevilla, Alberto Lens-Pardo, Paula Espinosa-Olarte, Carlos Carretero-Puche, Sonia Molina-Pinelo, Carlos Robles, Marta Benavent, Lourdes Gomez-Izquierdo, Marta Fierro-Fernández, Patricia Morales-Burgo, Paula Jimenez-Fonseca, Beatriz Anton-Pascual, Yolanda Rodriguez-Gil, Ana Teijo-Quintans, Anna La Salvia, Beatriz Rubio-Cuesta, Maria C Riesco-Martínez, Rocio Garcia-Carbonero
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms. Molecular oncology (2023)

Ana Teijo-Quintans.css-eqlu8i{font-size:small;padding-left:4px;} (Ana Teijo)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Teijo-Quintans (Ana Teijo)